Recalls: MedComp Catheters

The FDA has announced Class II recalls of the following MedComp catheter products because suture wings may crack or break, causing catheter dislocation, bleeding, or air emboli:

Recall: Accord Hydrochlorothiazide

The FDA has announced a recall of one lot of Accord Healthcare Hydrochlorothiazide Tablets USP, 12.5 mg, Lot PW05264 (46632 Bottles, NDC 16729-182-01).  Hydrochlorothiazide is used to manage hypertension. This lot is mislabeled and actually contains Spironolactone Tablets USP 25 mg, and in certain cases this substitution can lead to life-threatening hyperkalemia.  For details see https://www.fda.gov/Safety/Recalls/ucm618583.htm.  If you are in possession of Accord Hydrochlorothiazide that does not match the image below, or if you are unsure, return to your pharmacy or healthcare provider for confirmation.

FDA Warning re Cipro et al and Blood Sugar

The FDA has required new label warnings about blood sugar and mental health side effects of fluoroquinolone antibiotic drugs.  The most common fluoroquinolones are Cipro (ciprofloxacin), Avelox (moxifloxacin), and Levaquin (levofloxacin), but there are many others, most of which end in -floxacin.  The new label has many specific warnings and recommendations for diabetics.  For full details see https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm612979.htm.